American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

OraSure Technologies Inc

OSUR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

OSUR historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of OSUR by members of U.S. Congress

Politician Type Traded
Tom Malinowski House / D Sale $15,001 - $50,000 Feb 23, 2021
Tom Malinowski House / D Sale $1,001 - $15,000 Jan 11, 2021
Tom Malinowski House / D Sale $15,001 - $50,000 Dec 09, 2020
Tom Malinowski House / D Sale $1,001 - $15,000 Oct 08, 2020
Tom Malinowski House / D Sale $15,001 - $50,000 Oct 07, 2020
OSUR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
OSUR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
OSUR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in OSUR holdings by institutional investors

Insider Trading

Quarterly net insider trading by OSUR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $10,000 Jul 17, 2026 Issue: Budget/Appropriations Health Issues
  • $10,000 Apr 20, 2026 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 16, 2026 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 22, 2025 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 21, 2025 Issue: Budget/Appropriations Health Issues
  • $10,000 Apr 17, 2025 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 15, 2025 Issue: Budget/Appropriations Health Issues
  • $10,000 Sep 05, 2024 Issue: Health Issues Budget/Appropriations
  • $10,000 Jul 02, 2024 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 17, 2024 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 17, 2024 Issue: Health Issues Budget/Appropriations
  • $10,000 Jul 06, 2023 Issue: Health Issues Budget/Appropriations
  • $10,000 Jan 01, 2023 Issue: Health Issues Budget/Appropriations
  • $10,000 Oct 05, 2022 Issue: Health Issues Budget/Appropriations
  • $10,000 Jul 12, 2022 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 14, 2022 Issue: Health Issues Budget/Appropriations
  • $10,000 Jan 14, 2022 Issue: None
  • $10,000 Oct 04, 2021 Issue: None
  • $10,000 Jul 07, 2021 Issue: None
  • $10,000 Apr 07, 2021 Issue: None
  • $10,000 Jan 13, 2021 Issue: None
  • $10,000 Oct 08, 2020 Issue: None
  • $10,000 Jul 07, 2020 Issue: None
  • $10,000 Apr 09, 2020 Issue: None
  • $10,000 Jan 15, 2020 Issue: None
  • $10,000 Oct 04, 2019 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 09, 2019 Issue: Budget/Appropriations Health Issues
  • $10,000 Apr 11, 2019 Issue: Health Issues Budget/Appropriations
  • $10,000 Jan 07, 2019 Issue: Health Issues Budget/Appropriations
  • $10,000 Oct 10, 2018 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 11, 2018 Issue: Budget/Appropriations Health Issues
  • $10,000 Apr 11, 2018 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 10, 2018 Issue: Health Issues Budget/Appropriations
  • $10,000 Oct 06, 2017 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 12, 2017 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 11, 2017 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 06, 2017 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 14, 2016 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 13, 2016 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 07, 2016 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 14, 2016 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 14, 2015 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 10, 2015 Issue: Budget/Appropriations Health Issues
  • $10,000 Apr 13, 2015 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 16, 2015 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 17, 2014 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 07, 2014 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 16, 2014 Issue: Health Issues Budget/Appropriations
  • $10,000 Jan 15, 2014 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 09, 2013 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 12, 2013 Issue: Budget/Appropriations Health Issues
  • $10,000 Apr 17, 2013 Issue: Health Issues Budget/Appropriations
  • $10,000 Jan 15, 2013 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 18, 2012 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 13, 2012 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 09, 2012 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 12, 2012 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 13, 2011 Issue: Budget/Appropriations Health Issues
  • $10,000 Jul 18, 2011 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 15, 2011 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 20, 2011 Issue: Budget/Appropriations Health Issues
  • $10,000 Oct 08, 2010 Issue: Health Issues Budget/Appropriations
  • $10,000 Jul 13, 2010 Issue: Budget/Appropriations Health Issues
  • $10,000 Apr 15, 2010 Issue: Budget/Appropriations Health Issues
  • $10,000 Jan 07, 2010 Issue: Health Issues Budget/Appropriations
  • $10,000 Apr 20, 2009 Issue: Health Issues Budget/Appropriations
  • $17,347 Apr 02, 2009 Issue: Health Issues
  • $26,000 Apr 01, 2009 Issue: Health Issues
  • $16,000 Apr 01, 2009 Issue: Health Issues
  • $38,000 Nov 14, 2008 Issue: Health Issues
  • $19,000 Jul 22, 2008 Issue: Health Issues
  • $19,000 Apr 16, 2008 Issue: Health Issues Foreign Relations
  • $54,000 Feb 11, 2008 Issue: Government Issues
  • $54,000 Aug 13, 2007 Issue: Health Issues
  • $27,000 Feb 22, 2007 Issue: Health Issues
  • $40,000 Aug 21, 2006 Issue: Health Issues
  • $20,000 Feb 15, 2006 Issue: Health Issues
  • $11,952 Sep 14, 2005 Issue: Health Issues
  • $140,000 Apr 06, 2004 Issue: Health Issues
  • $140,000 Mar 15, 2004 Issue: Health Issues
  • $40,000 Aug 14, 2002 Issue: Manufacturing Defense Agriculture Aerospace Transportation Health Issues Medicare/Medicaid Budget/Appropriations Energy/Nuclear Roads/Highway Education Medical/Disease Research/Clinical Labs Science/Technology
  • $20,000 Feb 13, 2002 Issue: Defense Budget/Appropriations
  • $40,000 Aug 14, 2001 Issue: Budget/Appropriations
Revolving Door

Former government officials who have lobbied for OSUR

6 former government officials at 1 lobbying firm have lobbied for OSUR, most recently Jul 17, 2026.

  • Dane Christiansen Other Legislative Consultant Formerly Legislative Consultant · HEALTH AND MEDICINE COUNSEL · Jul 17, 2026
  • Philip Goglas Other Legislative Consultant Formerly Legislative Consultant · HEALTH AND MEDICINE COUNSEL · Jul 17, 2026
  • Kira Flaherty Other Legislative Consultant Formerly Legislative Consultant · HEALTH AND MEDICINE COUNSEL · Jul 17, 2026
  • Dale Dirks Other Legislative Consultant Formerly Legislative Consultant · HEALTH AND MEDICINE COUNSEL · Jul 06, 2023
  • Lodriguez Murray Other Legislative Consultant Formerly Legislative Consultant · HEALTH AND MEDICINE COUNSEL · Oct 06, 2017
  • Edward Taylor Other Legislative Consultant Formerly Legislative Consultant · HEALTH AND MEDICINE COUNSEL · Oct 06, 2017
Corporate Lobbying

OSUR Estimated quarterly lobbying spending

Revenue Breakdown

OSUR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
OSUR Income Statement
OSUR Balance Sheet
OSUR Cash Flow
U.S. Patents

New OSUR patent grants

  • Patent Title: Oral fluid collection device Jul. 21, 2026
  • Patent Title: Direct sample collection pad and method of use for assay diagnosis Feb. 24, 2026
  • Patent Title: Developer solution vial Aug. 05, 2025
  • Patent Title: Assay methods for improved analyte detection Jun. 24, 2025
  • Patent Title: Developer solution vial Feb. 04, 2025
  • Patent Title: Direct sample collection pad Sep. 24, 2024
  • Patent Title: Reagents, methods, and systems for detecting therapeutic agents to monitor adherence to nucleoside reverse transcriptase inhibitor metabolites Sep. 24, 2024
  • Patent Title: Developer solution vial Nov. 07, 2023
  • Patent Title: Products and methods for monitoring adherence to nucleoside reverse transcriptase inhibitor therapy Oct. 24, 2023
  • Patent Title: Funnel for an oral fluid collection device Jul. 25, 2023
  • Patent Title: Plunger for an oral fluid collection device Jul. 04, 2023
  • Patent Title: Direct sample collection pad Mar. 28, 2023
  • Patent Title: Cryo-surgical systems and methods of using the same Sep. 12, 2017
  • Patent Title: Cryo-surgical systems and methods of using the same Dec. 09, 2014
  • Patent Title: Sample collector and test device Mar. 18, 2014
  • Patent Title: Fluid sample collection device Dec. 25, 2012
  • Patent Title: Device for collection and assay of oral fluids Nov. 22, 2011
  • Patent Title: Cryosurgical device and method for cooling surfaces Oct. 18, 2011
  • Patent Title: Container and method for supporting home testing and diagnosis of infectious diseases Aug. 16, 2011
  • Patent Title: Sample collector and test device Feb. 01, 2011
  • Patent Title: Test device Jan. 25, 2011
  • Patent Title: Lateral flow assay device with multiple equidistant capture zones Dec. 28, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to OSUR from public contracts

OSUR News

Recent insights relating to OSUR

CNBC Recommendations

Recent picks made for OSUR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OSUR

OSUR Analyst Ratings

OSUR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
OSUR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $OSUR stock a Buy, Sell, or Hold?

  • What is the price target for $OSUR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

OSUR Top Shareholders
Shareholder
Shares Held
OSUR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $OSUR stock?

  • Who owns the most shares of $OSUR stock?

  • What funds own $OSUR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

OSUR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view OSUR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About OSUR

OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.

  • Address Bethlehem, PA
  • Market Cap 271.0 million
  • Employees 500
  • Industrial Classification Surgical & Medical Instruments & Apparatus

OraSure Technologies Inc (OSUR) Historical Stock Prices

OraSure Technologies Inc (OSUR) closed at $3.93 on September 24, 2026. Over the past year its adjusted close ranged from $2.11 to $4.50. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month+3.97%
  • 3 months-10.88%
  • Year to date+62.40%
  • 1 year+21.67%
  • 3 years-31.65%
  • 5 years-63.98%
  • Max-39.26%
See every congressional and insider trade on the OSUR price chart

Quiver Premium charts OSUR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 3.99 4.12 3.93 3.93 3.93 693,262
Sep 23, 2026 3.97 4.01 3.83 3.99 3.99 383,927
Sep 22, 2026 3.70 4.02 3.70 3.99 3.99 686,303
Sep 21, 2026 3.57 3.73 3.57 3.69 3.69 627,483
Sep 18, 2026 3.49 3.58 3.44 3.56 3.56 1,339,686
Sep 17, 2026 3.52 3.54 3.44 3.49 3.49 355,531
Sep 16, 2026 3.47 3.54 3.47 3.48 3.48 415,208
Sep 15, 2026 3.37 3.48 3.35 3.46 3.46 1,478,007
Sep 14, 2026 3.25 3.38 3.22 3.37 3.37 765,965
Sep 11, 2026 3.27 3.28 3.19 3.25 3.25 467,283
Sep 10, 2026 3.33 3.33 3.15 3.23 3.23 1,008,043
Sep 9, 2026 3.35 3.39 3.33 3.36 3.36 413,075
Sep 8, 2026 3.46 3.48 3.38 3.39 3.39 354,251
Sep 4, 2026 3.55 3.63 3.46 3.48 3.48 304,665
Sep 3, 2026 3.64 3.65 3.52 3.58 3.58 211,264
Sep 2, 2026 3.53 3.68 3.53 3.61 3.61 345,282
Sep 1, 2026 3.59 3.65 3.52 3.53 3.53 328,999
Aug 31, 2026 3.61 3.65 3.54 3.59 3.59 326,097
Aug 28, 2026 3.70 3.73 3.58 3.60 3.60 249,957
Aug 27, 2026 3.74 3.74 3.65 3.69 3.69 255,276
Aug 26, 2026 3.77 3.79 3.69 3.71 3.71 249,984
Aug 25, 2026 3.83 3.83 3.75 3.78 3.78 275,200
Aug 24, 2026 3.88 3.93 3.77 3.82 3.82 348,092
Aug 21, 2026 3.78 3.90 3.72 3.88 3.88 769,339
Aug 20, 2026 3.67 3.79 3.65 3.74 3.74 647,424
Aug 19, 2026 3.79 3.85 3.70 3.70 3.70 419,152
Aug 18, 2026 3.81 3.84 3.72 3.75 3.75 459,749
Aug 17, 2026 3.84 3.86 3.77 3.81 3.81 357,768
Aug 14, 2026 4.02 4.02 3.83 3.84 3.84 582,448
Aug 13, 2026 3.77 4.05 3.77 4.02 4.02 708,461
Aug 12, 2026 3.82 3.82 3.69 3.75 3.75 619,547
Aug 11, 2026 4.03 4.03 3.88 3.88 3.88 310,571
Aug 10, 2026 4.00 4.10 3.93 4.00 4.00 404,565
Aug 7, 2026 3.98 4.09 3.96 4.05 4.05 524,147
Aug 6, 2026 4.15 4.24 3.83 4.00 4.00 1,221,990
Aug 5, 2026 4.19 4.22 4.11 4.15 4.15 239,335
Aug 4, 2026 4.16 4.20 4.05 4.17 4.17 231,025
Aug 3, 2026 4.10 4.22 3.99 4.16 4.16 473,515
Jul 31, 2026 3.98 4.08 3.87 4.05 4.05 434,976
Jul 30, 2026 3.97 4.02 3.93 3.97 3.97 167,021
Jul 29, 2026 4.00 4.05 3.94 3.97 3.97 320,999
Jul 28, 2026 3.96 4.04 3.93 4.02 4.02 237,424
Jul 27, 2026 4.02 4.12 3.93 3.96 3.96 278,861
Jul 24, 2026 4.04 4.10 3.96 3.97 3.97 298,001
Jul 23, 2026 3.75 4.03 3.73 4.03 4.03 449,554
Jul 22, 2026 3.81 3.98 3.73 3.79 3.79 606,388
Jul 21, 2026 3.85 3.92 3.71 3.80 3.80 492,407
Jul 20, 2026 3.88 3.90 3.80 3.85 3.85 189,314
Jul 17, 2026 3.90 3.98 3.82 3.87 3.87 524,026
Jul 16, 2026 4.24 4.32 3.95 3.96 3.96 423,440
Jul 15, 2026 4.27 4.33 4.20 4.25 4.25 296,428
Jul 14, 2026 4.32 4.36 4.25 4.26 4.26 377,037
Jul 13, 2026 4.28 4.34 4.24 4.30 4.30 266,957
Jul 10, 2026 4.25 4.31 4.20 4.29 4.29 234,501
Jul 9, 2026 4.25 4.35 4.20 4.29 4.29 298,904
Jul 8, 2026 4.30 4.30 4.19 4.25 4.25 337,062
Jul 7, 2026 4.38 4.40 4.21 4.32 4.32 496,215
Jul 6, 2026 4.32 4.46 4.32 4.37 4.37 491,060
Jul 2, 2026 4.35 4.47 4.33 4.35 4.35 431,855
Jul 1, 2026 4.45 4.51 4.30 4.32 4.32 460,994
Jun 30, 2026 4.51 4.51 4.31 4.46 4.46 572,538
Jun 29, 2026 4.46 4.54 4.35 4.50 4.50 983,776
Jun 26, 2026 4.42 4.50 4.37 4.46 4.46 871,019
Jun 25, 2026 4.35 4.43 4.33 4.41 4.41 577,089
Jun 24, 2026 4.23 4.42 4.21 4.34 4.34 652,481
Jun 23, 2026 4.12 4.29 4.11 4.24 4.24 563,844
Jun 22, 2026 4.23 4.31 4.09 4.16 4.16 622,073
Jun 18, 2026 4.50 4.55 4.18 4.25 4.25 1,319,595
Jun 17, 2026 4.26 4.58 4.26 4.47 4.47 744,286
Jun 16, 2026 4.19 4.36 4.01 4.32 4.32 657,838
Jun 15, 2026 4.19 4.23 4.09 4.17 4.17 523,246
Jun 12, 2026 4.19 4.25 4.12 4.18 4.18 506,169
Jun 11, 2026 4.07 4.28 4.00 4.19 4.19 776,017
Jun 10, 2026 4.26 4.29 4.02 4.03 4.03 716,979
Jun 9, 2026 4.18 4.27 4.12 4.24 4.24 748,278
Jun 8, 2026 4.09 4.19 4.04 4.15 4.15 808,637
Jun 5, 2026 4.17 4.22 4.01 4.04 4.04 554,823
Jun 4, 2026 3.89 4.19 3.89 4.17 4.17 719,597
Jun 3, 2026 4.01 4.10 3.92 3.95 3.95 818,340
Jun 2, 2026 4.03 4.16 3.95 4.00 4.00 1,236,825
Jun 1, 2026 4.19 4.29 4.03 4.09 4.09 898,683
May 29, 2026 4.19 4.33 4.17 4.30 4.30 780,830
May 28, 2026 3.97 4.33 3.91 4.23 4.23 1,136,400
May 27, 2026 3.92 4.12 3.85 3.98 3.98 976,926
May 26, 2026 3.93 4.03 3.66 3.94 3.94 1,543,134
May 22, 2026 3.29 3.65 3.29 3.61 3.61 931,747
May 21, 2026 3.05 3.30 3.03 3.29 3.29 626,306
May 20, 2026 3.07 3.15 3.06 3.07 3.07 566,233
May 19, 2026 3.00 3.10 2.96 3.08 3.08 390,160
May 18, 2026 3.01 3.06 2.99 3.01 3.01 509,788
May 15, 2026 3.01 3.19 2.96 3.00 3.00 1,389,244
May 14, 2026 3.05 3.09 2.92 2.95 2.95 868,110
May 13, 2026 2.98 3.06 2.98 3.04 3.04 1,097,179
May 12, 2026 3.02 3.06 2.88 2.97 2.97 835,590
May 11, 2026 3.06 3.09 3.00 3.02 3.02 850,258
May 8, 2026 3.13 3.14 3.01 3.06 3.06 869,003
May 7, 2026 2.96 3.23 2.95 3.13 3.13 1,595,258
May 6, 2026 3.02 3.12 2.95 3.00 3.00 584,267
May 5, 2026 2.95 3.05 2.95 3.00 3.00 284,546
May 4, 2026 2.94 2.97 2.92 2.95 2.95 360,350
May 1, 2026 3.02 3.04 2.90 2.95 2.95 304,830
Apr 30, 2026 2.96 3.05 2.95 3.04 3.04 277,639
Apr 29, 2026 2.98 3.02 2.90 2.96 2.96 335,182
Apr 28, 2026 3.03 3.13 2.98 3.01 3.01 547,357
Apr 27, 2026 3.00 3.05 2.92 3.01 3.01 501,312
Apr 24, 2026 3.03 3.05 2.93 3.00 3.00 481,593
Apr 23, 2026 3.11 3.13 3.04 3.05 3.05 352,252
Apr 22, 2026 3.18 3.23 3.10 3.12 3.12 365,417
Apr 21, 2026 3.22 3.25 3.14 3.16 3.16 245,939
Apr 20, 2026 3.16 3.27 3.16 3.19 3.19 300,223
Apr 17, 2026 3.25 3.27 3.16 3.16 3.16 305,983
Apr 16, 2026 3.24 3.24 3.17 3.21 3.21 223,273
Apr 15, 2026 3.20 3.25 3.18 3.24 3.24 223,874
Apr 14, 2026 3.08 3.22 3.08 3.21 3.21 263,855
Apr 13, 2026 2.96 3.12 2.95 3.08 3.08 390,267
Apr 10, 2026 3.06 3.11 2.92 2.96 2.96 250,940
Apr 9, 2026 3.09 3.09 3.03 3.06 3.06 196,746
Apr 8, 2026 3.14 3.18 3.05 3.08 3.08 269,870
Apr 7, 2026 3.08 3.08 3.00 3.06 3.06 304,438
Apr 6, 2026 3.07 3.13 3.06 3.08 3.08 601,425
Apr 2, 2026 3.01 3.10 2.98 3.08 3.08 460,753
Apr 1, 2026 2.83 3.10 2.83 3.05 3.05 301,272
Mar 31, 2026 2.96 3.02 2.92 3.00 3.00 345,502
Mar 30, 2026 2.99 2.99 2.90 2.92 2.92 402,951
Mar 27, 2026 3.04 3.11 2.97 3.00 3.00 390,950
Mar 26, 2026 3.11 3.15 3.05 3.07 3.07 238,316
Mar 25, 2026 3.13 3.17 3.07 3.14 3.14 424,601
Mar 24, 2026 3.20 3.26 2.99 3.06 3.06 1,082,463
Mar 23, 2026 3.08 3.18 3.05 3.08 3.08 779,824
Mar 20, 2026 2.91 2.98 2.85 2.95 2.95 1,214,985
Mar 19, 2026 2.87 2.95 2.85 2.91 2.91 410,333
Mar 18, 2026 2.94 2.96 2.78 2.90 2.90 754,563
Mar 17, 2026 3.35 3.45 2.97 2.98 2.98 990,010
Mar 16, 2026 2.94 3.15 2.94 3.13 3.13 429,124
Mar 13, 2026 3.10 3.15 2.92 2.97 2.97 646,153
Mar 12, 2026 3.14 3.17 3.02 3.09 3.09 454,360
Mar 11, 2026 3.08 3.21 3.08 3.18 3.18 395,657
Mar 10, 2026 3.15 3.20 3.10 3.13 3.13 409,686
Mar 9, 2026 3.15 3.23 3.10 3.20 3.20 435,500
Mar 6, 2026 2.88 3.21 2.88 3.19 3.19 648,266
Mar 5, 2026 2.99 3.04 2.91 2.98 2.98 468,937
Mar 4, 2026 3.02 3.08 2.96 3.01 3.01 348,369
Mar 3, 2026 2.87 3.06 2.86 2.98 2.98 493,127
Mar 2, 2026 3.12 3.17 2.92 2.96 2.96 817,694
Feb 27, 2026 3.06 3.22 3.06 3.15 3.15 580,547
Feb 26, 2026 2.51 3.14 2.51 3.08 3.08 1,047,691
Feb 25, 2026 2.82 2.85 2.77 2.80 2.80 539,806
Feb 24, 2026 2.75 2.83 2.75 2.82 2.82 360,062
Feb 23, 2026 2.73 2.77 2.67 2.75 2.75 401,283
Feb 20, 2026 2.82 2.82 2.73 2.75 2.75 240,448
Feb 19, 2026 2.80 2.85 2.79 2.83 2.83 381,185
Feb 18, 2026 2.76 2.91 2.75 2.85 2.85 302,748
Feb 17, 2026 2.73 2.79 2.68 2.75 2.75 388,049
Feb 13, 2026 2.80 2.86 2.75 2.75 2.75 358,504
Feb 12, 2026 2.83 2.86 2.71 2.80 2.80 481,567
Feb 11, 2026 2.83 2.88 2.74 2.82 2.82 392,276
Feb 10, 2026 2.80 2.90 2.77 2.81 2.81 260,320
Feb 9, 2026 2.70 2.83 2.64 2.82 2.82 392,146
Feb 6, 2026 2.77 2.81 2.70 2.71 2.71 453,354
Feb 5, 2026 2.89 2.90 2.69 2.73 2.73 872,621
Feb 4, 2026 2.88 2.94 2.86 2.90 2.90 401,175
Feb 3, 2026 2.92 3.00 2.79 2.86 2.86 506,449
Feb 2, 2026 2.78 2.97 2.71 2.92 2.92 793,000
Jan 30, 2026 2.74 2.85 2.71 2.79 2.79 468,257
Jan 29, 2026 2.71 2.81 2.65 2.79 2.79 659,760
Jan 28, 2026 2.71 2.75 2.67 2.70 2.70 484,217
Jan 27, 2026 2.70 2.79 2.70 2.73 2.73 435,992
Jan 26, 2026 2.71 2.76 2.64 2.71 2.71 406,560
Jan 23, 2026 2.71 2.76 2.64 2.67 2.67 474,558
Jan 22, 2026 2.79 2.81 2.72 2.72 2.72 450,833
Jan 21, 2026 2.61 2.81 2.61 2.78 2.78 795,874
Jan 20, 2026 2.62 2.71 2.59 2.59 2.59 419,369
Jan 16, 2026 2.74 2.76 2.69 2.69 2.69 313,534
Jan 15, 2026 2.67 2.81 2.67 2.74 2.74 750,345
Jan 14, 2026 2.60 2.70 2.57 2.69 2.69 438,082
Jan 13, 2026 2.69 2.69 2.54 2.60 2.60 455,004
Jan 12, 2026 2.64 2.71 2.59 2.69 2.69 854,557
Jan 9, 2026 2.67 2.68 2.62 2.63 2.63 213,534
Jan 8, 2026 2.49 2.73 2.49 2.66 2.66 1,009,136
Jan 7, 2026 2.49 2.52 2.42 2.51 2.51 650,713
Jan 6, 2026 2.51 2.51 2.44 2.48 2.48 500,908
Jan 5, 2026 2.38 2.49 2.38 2.47 2.47 672,870
Jan 2, 2026 2.43 2.46 2.33 2.38 2.38 740,257
Dec 31, 2025 2.47 2.47 2.37 2.42 2.42 946,692
Dec 30, 2025 2.44 2.50 2.40 2.47 2.47 699,582
Dec 29, 2025 2.42 2.46 2.42 2.43 2.43 604,587
Dec 26, 2025 2.40 2.43 2.37 2.42 2.42 361,737
Dec 24, 2025 2.37 2.46 2.37 2.43 2.43 379,218
Dec 23, 2025 2.40 2.43 2.35 2.37 2.37 817,277
Dec 22, 2025 2.40 2.49 2.35 2.41 2.41 911,049
Dec 19, 2025 2.44 2.48 2.35 2.39 2.39 1,532,721
Dec 18, 2025 2.47 2.52 2.44 2.45 2.45 477,373
Dec 17, 2025 2.42 2.50 2.42 2.46 2.46 570,586
Dec 16, 2025 2.50 2.51 2.41 2.42 2.42 615,952
Dec 15, 2025 2.53 2.54 2.47 2.50 2.50 462,049
Dec 12, 2025 2.58 2.58 2.49 2.49 2.49 391,884
Dec 11, 2025 2.52 2.65 2.50 2.57 2.57 822,052
Dec 10, 2025 2.45 2.59 2.42 2.55 2.55 881,753
Dec 9, 2025 2.46 2.51 2.44 2.47 2.47 691,713
Dec 8, 2025 2.49 2.52 2.45 2.46 2.46 502,667
Dec 5, 2025 2.59 2.60 2.44 2.49 2.49 498,754
Dec 4, 2025 2.55 2.59 2.51 2.57 2.57 788,612
Dec 3, 2025 2.55 2.60 2.47 2.55 2.55 1,030,944
Dec 2, 2025 2.41 2.51 2.38 2.50 2.50 659,400
Dec 1, 2025 2.37 2.46 2.36 2.41 2.41 541,429
Nov 28, 2025 2.40 2.45 2.33 2.38 2.38 183,912
Nov 26, 2025 2.43 2.46 2.34 2.38 2.38 645,101
Nov 25, 2025 2.43 2.47 2.34 2.45 2.45 729,534
Nov 24, 2025 2.28 2.44 2.28 2.42 2.42 1,162,202
Nov 21, 2025 2.11 2.33 2.08 2.27 2.27 1,874,386
Nov 20, 2025 2.22 2.24 2.10 2.11 2.11 1,181,120
Nov 19, 2025 2.12 2.21 2.10 2.19 2.19 1,444,297
Nov 18, 2025 2.27 2.34 2.10 2.12 2.12 887,211
Nov 17, 2025 2.31 2.35 2.25 2.25 2.25 784,841
Nov 14, 2025 2.26 2.32 2.20 2.31 2.31 1,046,353
Nov 13, 2025 2.47 2.49 2.27 2.28 2.28 738,195
Nov 12, 2025 2.43 2.49 2.43 2.47 2.47 564,251
Nov 11, 2025 2.32 2.50 2.31 2.46 2.46 522,310
Nov 10, 2025 2.40 2.44 2.31 2.33 2.33 1,093,928
Nov 7, 2025 2.39 2.43 2.35 2.40 2.40 474,427
Nov 6, 2025 2.46 2.47 2.30 2.40 2.40 850,590
Nov 5, 2025 2.57 2.61 2.53 2.57 2.57 444,231
Nov 4, 2025 2.65 2.72 2.56 2.57 2.57 500,452
Nov 3, 2025 2.74 2.75 2.65 2.67 2.67 335,539
Oct 31, 2025 2.69 2.76 2.67 2.74 2.74 573,435
Oct 30, 2025 2.78 2.80 2.67 2.70 2.70 381,284
Oct 29, 2025 2.87 2.88 2.79 2.79 2.79 586,795
Oct 28, 2025 2.90 2.92 2.85 2.87 2.87 434,480
Oct 27, 2025 2.96 3.00 2.89 2.89 2.89 539,884
Oct 24, 2025 2.88 2.98 2.87 2.96 2.96 511,499
Oct 23, 2025 2.87 2.96 2.86 2.88 2.88 353,872
Oct 22, 2025 2.97 2.99 2.86 2.87 2.87 731,565
Oct 21, 2025 3.04 3.06 2.94 2.97 2.97 613,581
Oct 20, 2025 3.07 3.08 3.02 3.04 3.04 525,499
Oct 17, 2025 3.05 3.10 3.01 3.02 3.02 510,317
Oct 16, 2025 3.08 3.14 3.01 3.06 3.06 391,161
Oct 15, 2025 3.09 3.13 3.02 3.06 3.06 520,757
Oct 14, 2025 2.98 3.07 2.96 3.05 3.05 324,341
Oct 13, 2025 2.98 3.04 2.94 3.01 3.01 540,649
Oct 10, 2025 3.12 3.13 2.95 2.95 2.95 574,092
Oct 9, 2025 3.25 3.26 3.10 3.12 3.12 320,672
Oct 8, 2025 3.19 3.29 3.13 3.24 3.24 290,572
Oct 7, 2025 3.22 3.22 3.13 3.16 3.16 409,638
Oct 6, 2025 3.23 3.25 3.14 3.20 3.20 348,470
Oct 3, 2025 3.14 3.22 3.14 3.18 3.18 281,381
Oct 2, 2025 3.15 3.15 3.10 3.13 3.13 298,452
Oct 1, 2025 3.20 3.25 3.10 3.15 3.15 579,029
Sep 30, 2025 3.17 3.21 3.13 3.21 3.21 486,610
Sep 29, 2025 3.21 3.21 3.09 3.18 3.18 674,805
Sep 26, 2025 3.19 3.22 3.15 3.20 3.20 721,788
Sep 25, 2025 3.21 3.27 3.15 3.19 3.19 615,401
Sep 24, 2025 3.29 3.32 3.22 3.23 3.23 623,079

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
OraSure Technologies Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at OSUR, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation